跳至主要内容
临床试验/NCT02238912
NCT02238912已完成2 期

Evaluation of Preclinical Toxicity of a Siddha Formulation Kandhaga Rasayanam ( KR ) and Its Therapeutic Efficacy in Padarthamarai ( Dermatophytoses ) by an Open Clinical Trial

National institute of Siddha1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2012年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
50
试验地点
1
主要终点
skin scrapping test

研究概览

简要总结

this study is intended to find out the therapeutic efficacy of the siddha drug Kandhaga Rasayanam in Padarthamarai ( Ring worm infection )

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • patients clinically diagnosed with tinea infection.
  • direct microscopy skin scraping test positive.

排除标准

  • pregnant or nursing women.
  • use of other topical or oral antifungals, immunosuppressive drugs, anthelmintic drugs either currently or during 2 weeks preceeding initiation of drug trial.
  • allergy or hyperensitivity to any component of the drug.
  • clinical case of eczema, lichen planus, pityriasis versicolor, drug induced eruptions, urticaria, intertrigo, tinea ungium.
  • diabetic patients.

研究组 & 干预措施

Kandhaga Rasayanam- single arm

Experimental

Kandhaga Rasayanam- 2grams twice a day for 45 days

干预措施: kandhaga rasayanam (Drug)

结局指标

主要结局

skin scrapping test

时间窗: 45 days

次要结局

  • itching, quality of life(45 days)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Dr.R.Meena

PhD Research scholar

National institute of Siddha

研究点 (1)

Loading locations...

相似试验